Cytokintics looks great for a follow through on expansion breakout made a 2 month new high on surging volume due to being listed on the s&p smallcap 600 with last closing day being the largest in its range of the last 7-9 trading days. Buy stop in just above the breakout high with 1day expiry.
This stock is also undervalued, leading its peers with good fundamentals in recent headlines.
This stock is also undervalued, leading its peers with good fundamentals in recent headlines.
거래청산: 타겟 닿음:
hit and run job before earnings
